Steris this week announced that its jury trial against its subsidiary Isomedix Operations ended in a mistrial.

The ethylene market is seeing strong growth due to a number of relevant factors, one of which is the growing demand for pipe and building applications.

Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date. The Irish medical-device company said the case, which began on Dec. 4, was declared a ...

The Association for the Advancement of Medical Instrumentation (AAMI) recently released the Technical Information Report (TIR) 17, Compatibility of Materials Subject to Sterilization. This newest ...

Shell Nanhai BV and CNOOC have taken final investment decision to proceed with the proposed third major expansion of ethylene ...

Shell and Cnooc joint venture to expand petrochemical facility in China, adding ethylene cracker and specialty chemicals ...

Westlake Chemical Partners' Q3'24 results showed increased earnings due to higher ethylene prices and production volumes.

School of Chemistry, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse St., Dublin 2, Ireland ...

With this patent, PyroGenesis continues to accelerate the global deployment of its SPARC™ technology as a safe, effective, ...

DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix ...

Peachtree City shut down the Kedron Pool for a week after ethylene glycol (antifreeze) was found in the pool water. We had a ...

A joint venture of Shell and CNOOC plans to expand its petrochemical facility in south China's Guangdong province in a ...